Update on Omalizumab for Urticaria: What’s New in the Literature from Mechanisms to Clinic
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Update on Omalizumab for Urticaria: What’s New in the Literature from Mechanisms to Clinic
Authors
Keywords
Chronic inducible urticaria, Chronic spontaneous urticaria, Omalizumab, Pregnancy, Adverse events, Dosing intervals
Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume 18, Issue 5, Pages -
Publisher
Springer Nature
Online
2018-05-09
DOI
10.1007/s11882-018-0787-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria
- (2018) E Nettis et al. ACTA DERMATO-VENEREOLOGICA
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- (2018) T. Zuberbier et al. ALLERGY
- Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience
- (2018) Eustachio Nettis et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria
- (2018) L. Curto-Barredo et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment response to omalizumab in patients with refractory chronic spontaneous urticaria
- (2018) Nikolaos Syrigos et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria
- (2018) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
- (2018) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
- (2018) Murat Türk et al. ALLERGOLOGY INTERNATIONAL
- Evaluation of a Guidelines-Based Approach to the Treatment of Chronic Spontaneous Urticaria
- (2018) Jorge Sánchez et al. Journal of Allergy and Clinical Immunology-In Practice
- Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria
- (2018) Murat Türk et al. Journal of Allergy and Clinical Immunology-In Practice
- Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria
- (2018) Matthew D. Straesser et al. Journal of Allergy and Clinical Immunology-In Practice
- Consensus statement for the diagnosis and treatment of urticaria: A 2017 update
- (2018) Abhishek De et al. INDIAN JOURNAL OF DERMATOLOGY
- Successful treatment of refractory cholinergic urticaria with omalizumab
- (2017) Dimitra Koumaki et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma
- (2017) Carlos Iribarren et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab is effective in symptomatic dermographism—results of a randomized placebo-controlled trial
- (2017) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria
- (2017) Janine Gericke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria
- (2017) Ragip Ertas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
- (2017) Michihiro Hide et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Management of chronic inducible urticaria according to the guidelines: A prospective controlled study
- (2017) Emek Kocatürk et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Does omalizumab modify a course of recalcitrant chronic spontaneous urticaria?: A retrospective study in Asian patients
- (2017) Kanokvalai Kulthanan et al. JOURNAL OF DERMATOLOGY
- Omalizumab as Third-Line Therapy for Urticaria During Pregnancy
- (2017) LF Ensina et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study
- (2017) S.F. Thomsen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema
- (2017) M. Maurer et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria
- (2017) A.Y. Finlay et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
- (2017) Danilo Di Bona et al. RESPIRATORY MEDICINE
- Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
- (2017) Martin Metz et al. Theranostics
- Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study
- (2017) Michihiro Hide et al. ALLERGOLOGY INTERNATIONAL
- Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
- (2017) Zahava Vadasz et al. Journal of Allergy and Clinical Immunology-In Practice
- Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells
- (2017) Eva Serrano-Candelas et al. Scientific Reports
- Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial
- (2016) P. Staubach et al. ALLERGY
- Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience
- (2016) Luis Felipe Ensina et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population
- (2016) Kanokvalai Kulthanan et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases
- (2016) M. González-Medina et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience
- (2015) Luis Felipe Ensina et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy
- (2015) Jennifer Namazy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study
- (2015) Sarbjit S. Saini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
- (2014) Aidan Long et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation
- (2013) Donald W. MacGlashan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
- (2013) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omalizumab and the risk of malignancy: Results from a pooled analysis
- (2012) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search